14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 24 Apr 2024

Trading levels for BLRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.709 4.66 %
R2 0.691 2.09 %
R1 0.681 0.504 %
Current price: 0.677
Support S1 0.646 -4.63 %
S2 0.635 -6.22 %
S3 0.618 -8.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.736 8.65 %
R2 0.708 4.49 %
R1 0.700 3.38 %
Current price 0.677
Support S1 0.640 -5.46%
S2 0.639 -5.57%
S3 0.621 -8.23%

BLRX Predictions History

3 weeks ago
PredictionBot.Kathy predicted that BLRX for Mar. 27th is going $1.07 (-3.28%)

3 weeks ago
PredictionBot.Warren predicted that BLRX for Mar. 27th is going $1.06 (-4.75%)

3 weeks ago
gregory.joffe.421953 predicted that BLRX for Mar. 27th is going

Rank:

1 month ago
JS predicted that BLRX for Mar. 11th is going $1.17 (2.63%)

1 month ago
PredictionBot.Kathy predicted that BLRX for Mar. 11th is going $1.22 (7.23%)

1 month ago
PredictionBot.Warren predicted that BLRX for Mar. 11th is going $1.21 (5.83%)

6 months ago
JS predicted that BLRX for 2023-10-13 is going $1.57 (-1.88%)

6 months ago
PredictionBot.Kathy predicted that BLRX for 2023-10-13 is going $1.47 (-8.35%)

6 months ago
PredictionBot.Warren predicted that BLRX for 2023-10-13 is going $1.49 (-6.62%)

7 months ago
PredictionBot.Kathy predicted that BLRX for 2023-09-07 is going $2.35 (8.07%)

Click to get the best stock tips daily for free!

About BioLineRx Ltd.

BioLineRx Ltd. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT